Strategy

Photo

A Visible Turning Point for Oxea

Ten years ago, in March 2007, oxo chemicals producer Oxea was established as a buyout led by private-equity firm Advent International of oxo derivatives and oxo intermediates businesses from Celanese and European Oxo.

Photo

EPCA Celebrates its 50th Anniversary Annual Meeting in Budapest

After four busy days of business sessions and meetings by members of the global chemical business community, the EPCA 50th Anniversary Annual Meeting has concluded with its annual closing lunch featuring Herman Van Rompuy, former President of the European Council (2009-2014) who outlined his views on the future with all the influences globalisation is having on the world, and what that means for Europe.

164 more articles

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.